Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
Department of Medicine III, Clinical Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Br J Haematol. 2019 Aug;186(3):448-459. doi: 10.1111/bjh.15953. Epub 2019 May 24.
Given the lack of consistent data regarding the clinico-pathological features and clonal lymphomagenesis of patients with mucosa-associated lymphoid tissue (MALT) lymphoma and histological transformation (HT), we have systematically analysed 379 patients (32% gastric, 68% extra-gastric; median follow-up 52 months) diagnosed with HT at the Medical University Vienna 1999-2017, and reassessed tissues of identified patients by polymerase chain reaction (PCR)-based clonality analysis. HT was documented in 12/379 patients (3·2%) and occurred at a median time of 22 months (range; 6-202 months) after diagnosis of MALT lymphoma. By PCR-based clonality analysis, we detected a clear-cut clonal relationship of MALT lymphoma and diffuse large B-cell lymphoma (DLBCL) in 8 of 11 analysed cases proving that the large majority of DLBCL following MALT lymphoma are clonally-related and constitute a real transformation. Interestingly, HT occurred within the first 2·5 years after diagnosis in patients with clonal relationship, whereas time to aggressive lymphoma was longer in patients identified as clonally-unrelated (most likely secondary) lymphoma (82-202 months), suggesting that HT is an early event in this disease. Survival of patients with HT was poor with 6/12 dying at 1·5-33 months after HT, however, patients with localized gastric transformation had a superior outcome with only 1/6 dying due to progression of lymphoma.
鉴于黏膜相关淋巴组织(MALT)淋巴瘤和组织学转化(HT)患者的临床病理特征和克隆性淋巴发生缺乏一致的数据,我们系统地分析了 1999 年至 2017 年在维也纳医科大学诊断为 HT 的 379 例患者(32%为胃,68%为胃外;中位随访 52 个月),并通过聚合酶链反应(PCR)基于克隆性分析重新评估了确定患者的组织。HT 在 379 例患者中的 12 例(3.2%)中记录,在 MALT 淋巴瘤诊断后中位时间为 22 个月(范围:6-202 个月)。通过基于 PCR 的克隆性分析,我们在 11 例分析病例中的 8 例中检测到 MALT 淋巴瘤和弥漫性大 B 细胞淋巴瘤(DLBCL)之间明确的克隆关系,证明大多数 MALT 淋巴瘤后的 DLBCL 具有克隆相关性,构成真正的转化。有趣的是,在具有克隆关系的患者中,HT 发生在诊断后的前 2.5 年内,而在被鉴定为无克隆关系(很可能是继发性)淋巴瘤的患者中侵袭性淋巴瘤的时间更长(82-202 个月),这表明 HT 是该疾病的早期事件。HT 患者的生存不良,6/12 例患者在 HT 后 1.5-33 个月内死亡,但局部胃转化的患者结局较好,仅有 1/6 例患者因淋巴瘤进展而死亡。